| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.23M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $624.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sell | 108 | $30.00 | $3,240.00 | -4.1% | -37.0% | -18.4% | |
| Feb 16, 2022 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sell | 233 | $30.81 | $7,178.73 | -8.4% | -28.1% | -12.7% | |
| Feb 14, 2022 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sale+OE | 504 | $31.25 | $15,750.00 | -15.3% | -26.7% | -6.7% | |
| Jun 21, 2021 | Alenson Carman65 | Principal Accounting Officer | Sale+OE | 1,777 | $61.61 | $109,480.97 | -100% | -24.7% | -70.5% | |
| Jun 18, 2021 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 48,493 | $60.11 | $2,914,851.19 | -75.8% | -24.2% | -70.3% | |
| Jun 17, 2021 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,502 | $60.02 | $150,169.54 | -13.9% | -22.8% | -69.9% | |
| Jun 10, 2021 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 28,002 | $60.09 | $1,682,554.16 | -47.5% | -24.4% | -68.9% | |
| Jun 8, 2021 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 10,943 | $60.05 | $657,170.92 | -26.1% | -24.3% | -66.6% | |
| May 14, 2021 | Miles Darrin62 | Chief Commercial Officer | Sell | 3,462 | $55.41 | $191,829.42 | -32.4% | -20.2% | -59.9% | |
| Apr 20, 2021 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 17,611 | $55.12 | $970,636.12 | -36.2% | +1.1% | -52.7% |